Mutation in KARS: A novel mechanism for severe anaphylaxis

• Published in: Journal of allergy and clinical immunology Vol. 147; no. 5; pp. 1855 - 1864.e9
• Main Authors: Ribó, Pau, Guo, Yanru, Aranda, Juan, Ainsua-Enrich, Erola, Navinés-Ferrer, Arnau, Guerrero, Mario, Pascal, Mariona, de la Cruz, Cinthia, Orozco, Modesto, Muñoz-Cano, Rosa, Martin, Margarita
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-05-2021; Elsevier Limited
• Subjects: Amino acids; Anaphylaxis; Antibodies; Bone marrow; Cell activation; Confocal microscopy; Consciousness; Degranulation; Enzymes; Evolution; Fainting; Genetic counseling; Hypersensitivity; Hypotension; Immunoglobulin E; Inflammation; KARS; Kinases; lysyl-tRNA synthetase (LysRS); Mast cells; microphthalmia transcription factor; Microscopy; Molecular modelling; Mutation; Proline; Prostaglandin D2; Protein biosynthesis; Proteins; Software; Transcription activation; Transfection; tRNA; Venom; Spain; LysRS; PGD2; microphthalmia transcription factor; PMA; MITF; lysyl-tRNA synthetase (LysRS); mast cells; LysRS-S207(P); GFP; TRPM1; LysRS-WT; Anaphylaxis; KARS; 3xNFAT; MSC; WT
• ISSN: 0091-6749; 1097-6825
• DOI: 10.1016/j.jaci.2020.12.637

Anaphylaxis is a severe allergic reaction that can be lethal if not treated adequately. The underlying molecular mechanisms responsible for the severity are mostly unknown.
This study is based on a clinical case of a patient with extremely severe anaphylaxis to paper wasp venom. This patient has a mutation in the KARS gene, which encodes lysyl-tRNA synthetase (LysRS), a moonlight protein with a canonical function in protein synthesis and a noncanonical function in antigen dependent–FcεRI activation in mast cells. In this study, the objective was to characterize the mutation at the molecular level.
Analysis of the KARS mutation was carried out using biochemical and functional approaches, cell transfection, Western blot, confocal microscopy, cell degranulation, prostaglandin D2 secretion, and proteases gene transcription. Structural analysis using molecular dynamics simulations and well-tempered metadynamics was also performed.
The mutation found, P542R (proline was replaced by arginine at aminoacid 542), affects the location of the protein as we show in biochemical and structural analyses. The mutation resembles active LysRS and causes a constitutive activation of the microphthalmia transcription factor, which is involved in critical mast cell functions such as synthesis of mediators and granule biogenesis. Moreover, the structural analysis provides insights into how LysRS works in mast cell activation.
A link between the aberrant LysRS-P542R function and mast cell–exacerbated activation with increase in proinflammatory mediator release after antigen-IgE–dependent response could be established.
[Display omitted]